ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Loeb Named ACS President, Eyre President Elect

November 14, 1986

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011